272 related articles for article (PubMed ID: 11585118)
61. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.
Yilmaz S; Cakar G; Yildirim B; Sculean A
J Clin Periodontol; 2010 Jun; 37(6):544-50. PubMed ID: 20507378
[TBL] [Abstract][Full Text] [Related]
62. Proteolytic Mediators in Gestational Diabetes Mellitus and Gingivitis.
Akcalı A; Gümüş P; Özçaka Ö; Öztürk-Ceyhan B; Tervahartiala T; Husu H; Heikkinen AM; Sorsa T; Buduneli N
J Periodontol; 2017 Mar; 88(3):289-297. PubMed ID: 27762733
[TBL] [Abstract][Full Text] [Related]
63. Matrix metalloproteinases (MMP-8 and -9) and neutrophil elastase in gingival crevicular fluid of cyclosporin-treated patients.
Atilla G; Sorsa T; Rönka H; Emingil G
J Periodontol; 2001 Mar; 72(3):354-60. PubMed ID: 11327063
[TBL] [Abstract][Full Text] [Related]
64. Host-derived biomarkers at teeth and implants in partially edentulous patients. A 10-year retrospective study.
Ramseier CA; Eick S; Brönnimann C; Buser D; Brägger U; Salvi GE
Clin Oral Implants Res; 2016 Feb; 27(2):211-7. PubMed ID: 25682848
[TBL] [Abstract][Full Text] [Related]
65. Gingival crevicular fluid matrix metalloproteinase-8 levels predict treatment outcome among smokers with chronic periodontitis.
Leppilahti JM; Kallio MA; Tervahartiala T; Sorsa T; Mäntylä P
J Periodontol; 2014 Feb; 85(2):250-60. PubMed ID: 23659421
[TBL] [Abstract][Full Text] [Related]
66. Changes in transforming growth factor-beta1 in gingival crevicular fluid following periodontal surgery.
Kuru L; Griffiths GS; Petrie A; Olsen I
J Clin Periodontol; 2004 Jul; 31(7):527-33. PubMed ID: 15191588
[TBL] [Abstract][Full Text] [Related]
67. Treponema denticola associates with increased levels of MMP-8 and MMP-9 in gingival crevicular fluid.
Yakob M; Meurman JH; Sorsa T; Söder B
Oral Dis; 2013 Oct; 19(7):694-701. PubMed ID: 23294114
[TBL] [Abstract][Full Text] [Related]
68. Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or beta-tricalcium phosphate.
Döri F; Arweiler N; Gera I; Sculean A
J Periodontol; 2005 Dec; 76(12):2236-43. PubMed ID: 16332235
[TBL] [Abstract][Full Text] [Related]
69. Comparison of clinical, radiographic, and histometric measurements following treatment with guided tissue regeneration or enamel matrix proteins in human periodontal defects.
Windisch P; Sculean A; Klein F; Tóth V; Gera I; Reich E; Eickholz P
J Periodontol; 2002 Apr; 73(4):409-17. PubMed ID: 11990442
[TBL] [Abstract][Full Text] [Related]
70. [The use of Emdogain in periodontal and osseous regeneration].
Sculean A; Rathe F; Junker R; Becker J; Schwarz F; Arweiler N
Schweiz Monatsschr Zahnmed; 2007; 117(6):598-606. PubMed ID: 17691421
[TBL] [Abstract][Full Text] [Related]
71. Comparison of treatments of infrabony defects with enamel matrix derivative, guided tissue regeneration with a nonresorbable membrane and Widman modified flap. A pilot study.
Silvestri M; Ricci G; Rasperini G; Sartori S; Cattaneo V
J Clin Periodontol; 2000 Aug; 27(8):603-10. PubMed ID: 10959787
[TBL] [Abstract][Full Text] [Related]
72. Diabetes may affect the expression of matrix metalloproteinases and their inhibitors more than smoking in chronic periodontitis.
Bastos MF; Tucci MA; de Siqueira A; de Faveri M; Figueiredo LC; Vallim PC; Duarte PM
J Periodontal Res; 2017 Apr; 52(2):292-299. PubMed ID: 27363729
[TBL] [Abstract][Full Text] [Related]
73. The effect of subgingival antimicrobial therapy on the levels of stromelysin and tissue inhibitor of metalloproteinases in gingival crevicular fluid.
Pourtaghi N; Radvar M; Mooney J; Kinane DF
J Periodontol; 1996 Sep; 67(9):866-70. PubMed ID: 8884643
[TBL] [Abstract][Full Text] [Related]
74. Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases.
Sorsa T; Ding Y; Salo T; Lauhio A; Teronen O; Ingman T; Ohtani H; Andoh N; Takeha S; Konttinen YT
Ann N Y Acad Sci; 1994 Sep; 732():112-31. PubMed ID: 7978785
[TBL] [Abstract][Full Text] [Related]
75. Effects of enamel matrix derivative in nonsurgical periodontal therapy on pro-inflammatory profiles, microbial environment and clinical outcome: a randomized clinical trial.
Wehner C; Tur D; Durstberger G; Laky M; Laky B; Andrukhov O; Moritz A; Rausch-Fan X
Clin Oral Investig; 2023 Nov; 27(11):6493-6502. PubMed ID: 37843637
[TBL] [Abstract][Full Text] [Related]
76. Regulation of matrix metalloproteinases-8, -9 and endogenous tissue inhibitor-1 in oral biofluids during pregnancy and postpartum.
Özgen Öztürk V; Meriç P; Sorsa T; Tervahartiala T; Bostanci N; Nwhator SO; Emingil G
Arch Oral Biol; 2021 Apr; 124():105065. PubMed ID: 33556788
[TBL] [Abstract][Full Text] [Related]
77. Five-year results following treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration.
Sculean A; Donos N; Schwarz F; Becker J; Brecx M; Arweiler NB
J Clin Periodontol; 2004 Jul; 31(7):545-9. PubMed ID: 15191590
[TBL] [Abstract][Full Text] [Related]
78. Enamel matrix derivative and systemic antibiotics as adjuncts to non-surgical periodontal treatment: biologic response.
Giannopoulou C; Andersen E; Brochut P; Plagnat D; Mombelli A
J Periodontol; 2006 Apr; 77(4):707-13. PubMed ID: 16584354
[TBL] [Abstract][Full Text] [Related]
79. Regenerative therapy of infrabony defects with or without systemic doxycycline. A randomized placebo-controlled trial.
Röllke L; Schacher B; Wohlfeil M; Kim TS; Kaltschmitt J; Krieger J; Krigar DM; Reitmeir P; Eickholz P
J Clin Periodontol; 2012 May; 39(5):448-56. PubMed ID: 22385260
[TBL] [Abstract][Full Text] [Related]
80. Enamel matrix proteins in the treatment of intra-bony defects. A prospective 24-month clinical trial.
Francetti L; Del Fabbro M; Basso M; Testori T; Weinstein R
J Clin Periodontol; 2004 Jan; 31(1):52-9. PubMed ID: 15058375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
